BridgeBio Pharma Inc. (BBIO): Billionaire Tom Steyer Admires Upside Potential of This Stock
Summary
BridgeBio Pharma, Inc. (NASDAQ:BBIO) is a relatively recent addition to the 13F portfolio of Farallon Capital. The fund first disclosed a stake in the firm in t...
Original reporting
Open original sourceAFBytes is a read-only aggregator. Use the original source for full context and complete reporting.